Internet Explorer stöds inte längre. För bästa användarupplevelse rekommenderar vi att du använder Google Chrome, Safari, Edge eller Firefox som webbläsare.
Egetis Therapeutics AB is a Swedish pharmaceutical company that develops new therapies for life-threatening diseases related to oxidative stress. The initial goal is to develop a drug, PledOx®, that reduces serious side effects associated with chemotherapy. In 2020, they changed their name to Egetis Therapeutics AB from PledPaharma.
LEAD alumni 2012.
Information about cookies
We use cookies on our website to customize content and analyze our visitor traffic. Click here to read more about cookies. Läs mer
Cookie settings
Cookies save information about how you use the website, data that can be reused. Read more
These cookies are necessary for our website to work and can therefore not be turned off. They are used, for example, when setting personal preferences, logging in or filling out a form. You can set your browser to block or warn you about these cookies, but some parts of the website will not work then.
These cookies allow us to count the number of visits and traffic sources so that we can measure and improve our website. The information that these cookies collect is completely anonymous. If you do not allow these cookies, we do not know when you have visited our website.
